FDA Clears CT-Based AI For Detection of Mitral Annular Calcification
The AI-powered Bunkerhill MAC software reportedly facilitates chest CT detection and quantification of mitral annular calcification, which has been linked to higher cardiovascular risk and related mortality.
A Closer Look at the Mammo Enhance Heart Program: An Interview with Arthy Saravanan, MD
In a recent interview, Arthy Saravanan, M.D., discussed the potential impact of the Mammo Enhance Heart program from Radiology Partners and its potential impact in facilitating dual screening for breast cancer and cardiovascular risk.
Nine Takeaways from New Consensus on Abdominal Photon-Counting CT Protocols in Adults
Based on survey findings and subsequent voting from radiologists at nine facilities, the Society of Abdominal Radiology has issued new consensus recommendations on the use of adult abdominal photon-counting CT.
Current Perspectives on Prostate Cancer and Emerging Theranostic Agents, Part 1
In a recent interview, Emmanuel S. Antonarakis, M.D. discussed contributing factors to the recent American Cancer Society report about rising prostate cancer incidence and offered insights about the potential role of the radioligand agent 177Lu-PSMA-I&T for patients with mCRPC.
FDA Grants De Novo Approval for Cryoablation Treatment of Breast Cancer
In a multicenter trial, researchers found 96.3 percent of women with low-risk, early-stage breast cancer had no local recurrence after being treated with a combination of ProSense cryoablation and hormone therapy.
What a DBT Screening Study Reveals About False Positives with AI and Radiologist Assessments
In comparison to false positives with unassisted radiologist interpretations of DBT exams, AI-only false positive assessments were associated with a significantly higher total of false-positive findings as well as a 33 percent lower frequency of dense breasts, according to a new study of nearly 3,000 women who had screening DBT exams.